InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by RUBIN PAUL D. Director active across 1 company, notably BioAge Labs, Inc.. Aggregated, 4 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €136k. History available since 4 December 2025. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations